89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
| Year | Equity | Revenue | EBITDA | Fin. Res. | Net Inc. | Net Mar. | ROE | Cash | Debt | N.D. / EBITDA | OCF | CAPEX | FCF | Free | Div. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/23 TTM | 446 | 0 | -102 | 0 | -105 | L | L | 481 | 25 | L | -87 | 0 | 439 | -87 | 0 |
The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.